These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 9637702)
21. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells. Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452 [TBL] [Abstract][Full Text] [Related]
22. Correlation between human cytomegalovirus quantitative p72 antigenemia and viremia. Reina J; Blanco I; Munar M Clin Diagn Virol; 1996 Oct; 7(1):63-7. PubMed ID: 9077431 [TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus cultured from different major leukocyte subpopulations: association with clinical features in CMV immunoglobulin G-positive renal allograft recipients. Schäfer P; Tenschert W; Cremaschi L; Schröter M; Gutensohn K; Laufs R J Med Virol; 2000 Aug; 61(4):488-96. PubMed ID: 10897068 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of three polymerase chain reaction tests targeting morphological transforming region II, UL-83 gene and glycoprotein O gene for the detection of human cytomegalovirus genome in clinical specimens of immunocompromised patients in Chennai, India. Sowmya P; Madhavan HN; Therese KL Virol J; 2006 Mar; 3():20. PubMed ID: 16571138 [TBL] [Abstract][Full Text] [Related]
25. Monitoring human cytomegalovirus infection in transplant recipients. Baldanti F; Lilleri D; Gerna G J Clin Virol; 2008 Mar; 41(3):237-41. PubMed ID: 18203657 [TBL] [Abstract][Full Text] [Related]
26. Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus. Zhang C; Shen K; Jiang Z; He X Chin Med J (Engl); 2001 Dec; 114(12):1309-12. PubMed ID: 11793860 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp65-antigen test in guiding pre-emptive antiviral treatment. Allice T; Cerutti F; Pittaluga F; Varetto S; Franchello A; Salizzoni M; Ghisetti V J Virol Methods; 2008 Mar; 148(1-2):9-16. PubMed ID: 18045702 [TBL] [Abstract][Full Text] [Related]
28. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host. Lilleri D; Zelini P; Fornara C; Comolli G; Revello MG; Gerna G Clin Immunol; 2009 Jun; 131(3):395-403. PubMed ID: 19268633 [TBL] [Abstract][Full Text] [Related]
29. Development and application of a novel multiplex polymerase chain reaction for semi-quantitation of human Cytomegalovirus in clinical specimens. Madhavan HN; Sowmya P; Therese KL; Malathi J J Virol Methods; 2007 May; 141(2):166-72. PubMed ID: 17222918 [TBL] [Abstract][Full Text] [Related]
30. Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial. Gerna G; Baldanti F; Lilleri D; Parea M; Torsellini M; Castiglioni B; Vitulo P; Pellegrini C; Viganò M; Grossi P; Revello MG Transplantation; 2003 Apr; 75(7):1012-9. PubMed ID: 12698090 [TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus persistence in macrophages and endothelial cells. Fish KN; Stenglein SG; Ibanez C; Nelson JA Scand J Infect Dis Suppl; 1995; 99():34-40. PubMed ID: 8668941 [TBL] [Abstract][Full Text] [Related]
32. Discordant detection of human cytomegalovirus DNA from peripheral blood mononuclear cells, granulocytes and plasma: correlation to viremia and HCMV infection. Hamprecht K; Steinmassl M; Einsele H; Jahn G J Clin Virol; 1998 Aug; 11(2):125-36. PubMed ID: 9785214 [TBL] [Abstract][Full Text] [Related]
33. In situ detection of DNA and mRNA of human cytomegalovirus to distinguish different forms of viral infection in leukocytes. Zawilinska B; Bulek K; Kopec J; Kosz-Vnenchak M Acta Biochim Pol; 2006; 53(3):457-61. PubMed ID: 17019440 [TBL] [Abstract][Full Text] [Related]
34. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients. Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. Revello MG; Zavattoni M; Baldanti F; Sarasini A; Paolucci S; Gerna G J Clin Virol; 1999 Sep; 14(1):57-66. PubMed ID: 10548131 [TBL] [Abstract][Full Text] [Related]
36. Human cytomegalovirus proteins PP65 and IEP72 are targeted to distinct compartments in nuclei and nuclear matrices of infected human embryo fibroblasts. Arcangeletti MC; De Conto F; Ferraglia F; Pinardi F; Gatti R; Orlandini G; Calderaro A; Motta F; Medici MC; Martinelli M; Valcavi P; Razin SV; Chezzi C; Dettori G J Cell Biochem; 2003 Dec; 90(5):1056-67. PubMed ID: 14624464 [TBL] [Abstract][Full Text] [Related]
37. [Interrelationship between human cytomegalovirus infection and chemokine]. Murayama T Nihon Rinsho; 1998 Jan; 56(1):69-74. PubMed ID: 9465667 [TBL] [Abstract][Full Text] [Related]
38. [The study on high-resolution HLA and human cytomegalovirus (HCMV) viremia in bone marrow transplantation recipients]. Ma YD; Li MH; Meng XQ; Huang YP; Hu JH; Chin XM; Fan J; Ma WH Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Dec; 25(6):427-30. PubMed ID: 22734226 [TBL] [Abstract][Full Text] [Related]
39. A novel pattern of pp65-positive cytomegalic endothelial cells circulating in peripheral blood from a renal transplant recipient. Ye Q; Luo G; He X; Zheng L; Dong X; Xu X; Gao J; Nilsson-Ehle P; Xu N Acta Histochem; 2004; 106(2):107-10. PubMed ID: 15147631 [TBL] [Abstract][Full Text] [Related]
40. Modification of the major tegument protein pp65 of human cytomegalovirus inhibits virus growth and leads to the enhancement of a protein complex with pUL69 and pUL97 in infected cells. Becke S; Fabre-Mersseman V; Aue S; Auerochs S; Sedmak T; Wolfrum U; Strand D; Marschall M; Plachter B; Reyda S J Gen Virol; 2010 Oct; 91(Pt 10):2531-41. PubMed ID: 20592110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]